These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 21688282

  • 1. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.
    Bhala N, Angulo P, van der Poorten D, Lee E, Hui JM, Saracco G, Adams LA, Charatcharoenwitthaya P, Topping JH, Bugianesi E, Day CP, George J.
    Hepatology; 2011 Oct; 54(4):1208-16. PubMed ID: 21688282
    [Abstract] [Full Text] [Related]

  • 2. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, Eslam M, Gonzalez-Fabian L, Alvarez-Quiñones Sanz M, Conde-Martin AF, De Boer B, McLeod D, Hung Chan AW, Chalasani N, George J, Adams LA, Romero-Gomez M.
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [Abstract] [Full Text] [Related]

  • 3. NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.
    Treeprasertsuk S, Björnsson E, Enders F, Suwanwalaikorn S, Lindor KD.
    World J Gastroenterol; 2013 Feb 28; 19(8):1219-29. PubMed ID: 23482703
    [Abstract] [Full Text] [Related]

  • 4. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, Mills AS.
    Am J Gastroenterol; 2003 Sep 28; 98(9):2064-71. PubMed ID: 14499789
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.
    Angulo P, Bugianesi E, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Barrera F, Haflidadottir S, Day CP, George J.
    Gastroenterology; 2013 Oct 28; 145(4):782-9.e4. PubMed ID: 23860502
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.
    Kim D, Kim WR, Kim HJ, Therneau TM.
    Hepatology; 2013 Apr 28; 57(4):1357-65. PubMed ID: 23175136
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Liver fibrosis scores predict liver disease mortality in the United States population.
    Unalp-Arida A, Ruhl CE.
    Hepatology; 2017 Jul 28; 66(1):84-95. PubMed ID: 28195363
    [Abstract] [Full Text] [Related]

  • 12. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B.
    Dig Liver Dis; 2008 Sep 28; 40(9):743-8. PubMed ID: 18339592
    [Abstract] [Full Text] [Related]

  • 13. ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis.
    Calzadilla-Bertot L, Vilar-Gomez E, Wong VW, Romero-Gomez M, Aller-de la Fuente R, Wong GL, Castellanos M, Eslam M, Desai AP, Jeffrey GP, George J, Chalasani N, Adams LA.
    Hepatology; 2021 Jun 28; 73(6):2238-2250. PubMed ID: 32978796
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel non-invasive score to predict cirrhosis in the era of hepatitis C elimination: A population study of ex-substance users in Singapore.
    Zhao Y, Thurairajah PH, Kumar R, Tan J, Teo EK, Hsiang JC.
    Hepatobiliary Pancreat Dis Int; 2019 Apr 28; 18(2):143-148. PubMed ID: 30558838
    [Abstract] [Full Text] [Related]

  • 19. Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD.
    Xun YH, Guo JC, Lou GQ, Jiang YM, Zhuang ZJ, Zhu MF, Luo Y, Ma XJ, Liu J, Bian DX, Shi JP.
    Clin Exp Pharmacol Physiol; 2014 Sep 28; 41(9):643-9. PubMed ID: 24837195
    [Abstract] [Full Text] [Related]

  • 20. Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases.
    Ochi H, Hirooka M, Koizumi Y, Miyake T, Tokumoto Y, Soga Y, Tada F, Abe M, Hiasa Y, Onji M.
    Hepatology; 2012 Oct 28; 56(4):1271-8. PubMed ID: 22488593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.